Clinical Trials in Tennessee

Showing 18521-18540 of 20,239 trials

Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-Sensitive Metastatic Breast Cancer

NCT01205685

Erlotinib attacks a part of cancer cells that helps them live and grow. Studies done in human beings show that this drug can make a difference in the way anti-estrogens work in hormone-sensitive breast cancers. OSI-906 attacks a different part of the cancer cell that helps them live and grow. Studies done in the laboratory show that OSI-906 can make a difference in the way anti-estrogens work in hormone-sensitive breast cancers.

Hormone-sensitive Metastatic Breast Cancer

Vanderbilt-Ingram Cancer Center11 participantsStarted May 2010

Franklin, Tennessee, United States • Nashville, Tennessee, United States • Nashville, Tennessee, United States

COMPLETEDPhase 229 miles

Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

NCT00639769

RATIONALE: Drugs used in chemotherapy, such as irinotecan and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: To determine if CPT-11 given together with cisplatin is effective in treating recurrent or metastatic head and neck cancer.

Head and Neck Cancer

Vanderbilt-Ingram Cancer Center41 participantsStarted Feb 2002

Macon, Georgia, United States • Chattanooga, Tennessee, United States • Jackson, Tennessee, United States +5 more locations

Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-Sensitive Metastatic Breast Cancer

Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Find Trials by Condition in Tennessee

The Effect of Forced Air Warming During Cesarean Section on Postoperative Infectious Morbidity

Attain Success Clinical Trial

SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme

Opioid Titration in the Hospice Setting: Barriers Assessment and Modification of the Model Order Sheet and Protocol

Family Quality of Life Among Families With a Member Who is a Cancer Patient

NTX Wireless Patient Monitoring System

Survival Study Of Oncophage® vs. Observation In Patients With Kidney Cancer

Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program

ReStore Thrombectomy Trial for Flow Restoration in Acute Ischemic Stroke Patients

Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting

Study of VI-0521 Compared to Placebo in Treatment of Diabetes and Obesity in Adults With Obesity-Related Co-Morbid Conditions

A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer

AG-858 in Patients Who Are Cytogenetically Positive After Treatment With Gleevec™

Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)

Physiological Response to Exercise: Sensor Evaluation at Specified Exertions

28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years

Treatment of Androgenetic Alopecia in Females, 12 Beam

Cetuximab in Patients With Progressive or Recurrent Endometrial Cancer